Improvement of non-alcoholic fatty liver disease treatment
Aim of investigation. To estimate efficacy of combined hepatotropic drug «Hepaguard Active» for prevention of progression of non-alcoholic fatty liver disease (NAFLD) at steatosis stage.Material and methods. Overall 25 patients with verified NAFLD at steatosis stage were studied. All patients receiv...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2014-10-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/1127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|